DE69227347D1 - Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten - Google Patents

Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten

Info

Publication number
DE69227347D1
DE69227347D1 DE69227347T DE69227347T DE69227347D1 DE 69227347 D1 DE69227347 D1 DE 69227347D1 DE 69227347 T DE69227347 T DE 69227347T DE 69227347 T DE69227347 T DE 69227347T DE 69227347 D1 DE69227347 D1 DE 69227347D1
Authority
DE
Germany
Prior art keywords
antagonists
amylin
screening procedures
amylin agonists
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227347T
Other languages
English (en)
Other versions
DE69227347T2 (de
Inventor
Kevin Beaumont
Timothy Rink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Publication of DE69227347D1 publication Critical patent/DE69227347D1/de
Application granted granted Critical
Publication of DE69227347T2 publication Critical patent/DE69227347T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE69227347T 1991-03-15 1992-03-13 Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten Expired - Fee Related DE69227347T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,231 US5264372A (en) 1991-03-15 1991-03-15 Receptor-based screening methods for amylin agonists and antagonists
PCT/US1992/002125 WO1992016845A1 (en) 1991-03-15 1992-03-13 Receptor-based screening methods for amylin agonists and antagonists

Publications (2)

Publication Number Publication Date
DE69227347D1 true DE69227347D1 (de) 1998-11-26
DE69227347T2 DE69227347T2 (de) 1999-03-18

Family

ID=24689539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227347T Expired - Fee Related DE69227347T2 (de) 1991-03-15 1992-03-13 Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten

Country Status (13)

Country Link
US (1) US5264372A (de)
EP (1) EP0529065B1 (de)
JP (1) JPH05508226A (de)
AT (1) ATE172540T1 (de)
AU (1) AU1663092A (de)
CA (1) CA2082929A1 (de)
DE (1) DE69227347T2 (de)
DK (1) DK0529065T3 (de)
IL (5) IL101233A (de)
MX (1) MX9201113A (de)
TW (1) TW324064B (de)
WO (1) WO1992016845A1 (de)
ZA (1) ZA921884B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
DE69333683T2 (de) * 1992-05-15 2005-10-27 Amylin Pharmaceuticals, Inc., San Diego Antikörper-testbesteck zur bestimmung von amylin
AU6249594A (en) * 1993-02-12 1994-08-29 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
WO1994021665A1 (en) * 1993-03-24 1994-09-29 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
EP0717635B1 (de) * 1993-09-07 2000-11-15 Amylin Pharmaceuticals, Inc. Methoden zur regulation der den magen und darm betreffenden motilitaet
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1996031526A1 (en) * 1995-04-06 1996-10-10 Amylin Pharmaceuticals, Inc. Anti-obesity agents
US6143718A (en) 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
ATE417622T1 (de) * 1996-08-08 2009-01-15 Amylin Pharmaceuticals Inc Regulation gastrointestinaler beweglichkeit
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
AU739020B2 (en) * 1997-01-07 2001-10-04 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
US7101853B2 (en) 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO1999005161A1 (en) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
CA2329513A1 (en) * 1998-05-26 1999-12-02 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of rna molecules
US7399489B2 (en) * 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
KR20070051948A (ko) 1999-01-14 2007-05-18 아밀린 파마슈티칼스, 인크. 글루카곤 억제용 제약학적 조성물
US20030087820A1 (en) * 1999-01-14 2003-05-08 Young Andrew A. Novel exendin agonist formulations and methods of administration thereof
US6924264B1 (en) 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
EP1175443A1 (de) 1999-04-30 2002-01-30 Amylin Pharmaceuticals, Inc. Modifizierte exendine und exendin agonisten
EP1194778A2 (de) * 1999-07-13 2002-04-10 Amylin Pharmaceuticals, Inc. Verwendung der area postrema zur identifizierung von therapeutischen verbindungen
AU2002218218A1 (en) * 2000-10-10 2002-04-22 Austrian Nordic Biotherapeutics Ag A novel system for the evaluation of the activity and/or specificity of a viral component
US20040005997A1 (en) * 2002-06-27 2004-01-08 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass of function using amylin receptors
WO2004014947A1 (en) * 2002-08-06 2004-02-19 Aventis Pharma Deutschland Gmbh Method for isolating an intestinal cholesterol binding protein
WO2004037168A2 (en) * 2002-10-18 2004-05-06 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20040214180A1 (en) * 2003-04-28 2004-10-28 Hironori Kobayashi Method and kit for determining quantity of protein
US20070275877A1 (en) * 2003-08-29 2007-11-29 Amylin Pharmaceuticals, Inc. Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
JP2008500281A (ja) * 2004-02-11 2008-01-10 アミリン・ファーマシューティカルズ，インコーポレイテッド アミリンファミリーペプチドおよびそれらを作成し使用するための方法
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
AU2005295043A1 (en) * 2004-10-08 2006-04-20 Amylin Pharmaceuticals, Inc. Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
ES2325773T5 (es) 2004-11-01 2014-02-24 Amylin Pharmaceuticals, Llc. Tratamiento de la obesidad y de los trastornos relacionados
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
US7879572B2 (en) * 2004-11-12 2011-02-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Regulation of F1-ATPase beta subunit cellular location
DE602006016760D1 (de) 2005-03-31 2010-10-21 Amylin Pharmaceuticals Inc Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
EP1912666A2 (de) * 2005-07-22 2008-04-23 Amylin Pharmaceuticals, Inc. Verwendung von amylin und amylin-agonisten als kardioprotektive oder myoprotektive mittel
WO2009064298A1 (en) * 2007-11-14 2009-05-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity and obesity related diseases and disorders
US9445992B2 (en) 2009-11-25 2016-09-20 Arisgen Sa Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus
DE69022501T2 (de) * 1989-07-10 1996-02-01 Amylin Pharmaceuticals Inc Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten.

Also Published As

Publication number Publication date
EP0529065B1 (de) 1998-10-21
EP0529065A4 (en) 1993-10-20
DK0529065T3 (da) 1999-06-28
TW324064B (en) 1998-01-01
IL120081A0 (en) 1997-04-15
WO1992016845A1 (en) 1992-10-01
EP0529065A1 (de) 1993-03-03
IL101233A (en) 1997-04-15
DE69227347T2 (de) 1999-03-18
IL120082A0 (en) 1997-04-15
AU1663092A (en) 1992-10-21
CA2082929A1 (en) 1992-09-16
US5264372A (en) 1993-11-23
IL101233A0 (en) 1992-11-15
JPH05508226A (ja) 1993-11-18
MX9201113A (es) 1992-10-01
IL120082A (en) 1998-12-27
ATE172540T1 (de) 1998-11-15
ZA921884B (en) 1993-08-03
IL120081A (en) 1998-12-27

Similar Documents

Publication Publication Date Title
DE69227347D1 (de) Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten
DE69940958D1 (de) Bestimmungsmethode fur liganden der nuklearen rezeptoren
ES2182736T1 (es) Procedimientos para el ensayo de la actividad receptora y las construcciones utiles en dichos procedimientos.
SE8400788D0 (sv) Novel adenosine receptor antagonists
DE69828827D1 (de) Verbessertes Prüfsystem für Proben
DE69738739D1 (de) Verfahren für das Entwerfen von kleinen Erythropoietin Mimetika
ES2147729T3 (es) Dominios de la region extracelular de polipeptidos receptores de factor de crecimiento derivado de plaquetas humano.
WO1999024463A3 (en) Signal peptide-containing proteins
DK1141237T3 (da) PTH-receptor og screeningsassay der anvender denne
DE69127788D1 (de) System zur Verdünnung von Flüssigkeit für Analysezwecke
ATE291615T1 (de) Testverfahren für agonisten und antagonisten des g protein gekoppelten rezeptors
DE60138808D1 (de) G-protein gekoppelte rezeptoren
AR010041A1 (es) Agonistas multifuncionales quimericos de receptores de hematopoyetina
DE69022860D1 (de) Prüfmodusumschaltsystem für LSI.
ZA912303B (en) Protein partner screening assays and uses thereof
WO1998055509A3 (en) Two human dnaj-like proteins
DE69740057D1 (de) Transkriptionaler Intermediärfaktor 2
DE69731964D1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
ATE457317T1 (de) Chemokine rezeptor
DK0677117T3 (da) Sondring mellem HTLV-I og HTLV-II under anvendelse af syntetiske peptider
DK72082A (da) Cytoreceptor-proeve
WO2000018915A3 (en) Membrane-associated organizational proteins
WO2000026243A3 (en) Transmembrane 4 proteins
ATE301833T1 (de) Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz
TH18474A (th) ลำดับดีเอนเอที่มีรหัสสำหรับหน่วยรับ bmp

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee